WASHINGTON (AFP) - Injections of botulinum toxin A, or Botox, into the prostate gland eased the symptoms of enlarged prostate in men for up to a year, according to the results of a small study published Wednesday.

Erectile dysfunction herbal remedy
at the Chang Gung University Medical College, Taiwan, and the University of Pittsburgh School of Medicine, Complete stretching a new exercise program for health and vitality
, based their study on 37 men with benign prostatic hyperplasia (BHP), or enlarged prostate.

All patients received a single injection of Botox into their prostate, the researchers said in their paper published in a summary ahead of this week's American Urological Ed pills
's annual conference, in Annaheim, Erectile dysfunction home remedy.

A year into the treatment 27 patients - 73 percent of the group - experienced a 30 percent improvement in urinary tract symptoms and quality of life, said Dr Yao-Chi Chuang, chief investigator for the Taiwanese university.

Chuang said Botox - a popular, surgery-free cosmetic treatment for wrinkles - reduces the size of the prostate gland through a cellular process called apoptosis, in which the prostate cells die in a programmed manner.

The treatment posed no significant side effects, such as stress urinary incontinence or erectile dysfunction, said Pittsburgh's Michael Chancellor, senior author of the study.

The reduction in size of the prostate can improve urine flow and decrease residual urine left in the bladder, he said.

“Our results are encouraging because they indicate that Botox could represent a simple, safe and effective treatment for enlarged prostate that has long-term benefits,” Chancellor added.

BHP is one of the most common diseases affecting men as they age. More than half of all men over the age of 60 and by age 80 develop enlarged prostates, the researchers said.

Forty to 50 percent will develop symptoms of BHP, including more frequent urination, urinary tract infections, the inability to completely empty the bladder and, in severe cases, eventual damage to the bladder and kidneys, they added.

Botox is a powerful neurotoxin introduced nearly two decades ago. It is used to cure some facial problems but is best known for its cosmetic qualities in paralysing facial muscles and thus giving foreheads a wrinkle-free appearance.

NEW YORK (Reuters Health) - An expanding waistline in older men is associated with worsening lower urinary tract symptoms and poorer sexual function, according to research reported at the American Urological Association meeting in Anaheim.

At a press briefing, Dr. Steven A. Kaplan from Weill Cornell Medical College, New York, noted that waist size is one component of the so-called metabolic syndrome, which signifies an elevated risk of heart disease and diabetes. “It is becoming very clear that when you have multiple drug dysfunction erectile medication of the metabolic syndrome you can bet that you will have components of pelvic dysfunction, which we would define as sexual dysfunction and voiding dysfunction,” Kaplan said.

He and his colleagues tested the idea that waist circumference may be a useful predictor of prostate volume and the severity of pelvic dysfunction.

They grouped 88 men (average age, 62 years) with moderate or severe untreated voiding symptoms by waist circumference: 30-36 inches, 36-40 inches, and more than 40 inches.

More symptom waist circumference was significantly associated with “every parameter we looked at,” Kaplan said. Prostate volume, PSA level, voiding symptom score, erectile dysfunction, and ejaculatory dysfunction all cause and treatment of erectile dysfunction as waist size increased, he explained.

“The results were simply remarkable. They even surprised us,” he commented. “We have no doubt, at least from this cohort of patients, that increasing waist circumference is associated with worsening male health — voiding and sexual function.”

This study, Kaplan concluded, shows that obese men are at increased risk of pelvic dysfunction and can be “easily diagnosed” by measuring waist circumference.

BodyLogicMD's Dr. Jennifer Landa seminar will discuss the symptoms of andropause (the male menopause) and low testosterone and how bioidentical hormone therapy, integrated with fitness and nutrition, can help.

Orlando, FL (PRWEB) September 26, 2007 — BodyLogicMD's Dr. Jennifer Landa seminar will discuss the symptoms of andropause (the male menopause) and low testosterone and how bioidentical hormone therapy, integrated with fitness and nutrition, can help.

What:

Andropause (The Male Menopause) and Bioidentical Hormone Therapy Seminar

Where:

BodyLogicMD - Dr. Jennifer Landa's Orlando Office
175 Lookout Place Suite 201
Maitland, FL 32751
888.799.5821

When:

October 24, 2007
6:00pm-7:00pm

Who should attend?

Men and the women who love them, ages 35+ suffering from the symptoms of hormonal imbalance such as lost libido, erectile problems, sleep problems, fatigue, muscle loss, weight gain and thinning hair.

Admission:

RSVP Required - Register Online.
Includes Light Dysfunction erectile natural treatment, Limited Space Available

Register Now:

Contact BodyLogicMD at 888-799-5821 or www.bodylogicmd.com/seminars.html

Details:
Andropause, also known as the male menopause or MANopause, is the result of a gradual drop in testosterone. Symptoms of low testosterone manifest in a number of ways including physical, emotional, psychological and behavioral change.

BodyLogicMD's Dr. Jennifer Landa will discuss the symptoms of andropause and low testosterone and how bioidentical hormone therapy integrated with fitness and nutrition can help.

About Dr. Landa
As a gynecologist and hormone therapy expert, Dr. Jennifer Landa helps patients achieve wellness through hormone balance and preventive medicine. She dedicates her full-time practice to using anti-aging medicine, nutrition, and fitness to help women and men resolve menopause and andropause symptoms, including weight gain, sexual dysfunction, declining energy levels and stress.

About BodyLogicMD
Founded in 2003, BodyLogicMD is a national network of anti-aging physicians herbal erectile dysfunction treatment in natural bioidentical hormone therapy integrated with fitness and nutrition serving men and women suffering from hormonal imbalance, menopause and andropause. Suzanne Somers' latest book, “Ageless: The Naked Truth About Bioidentical Hormones,” features BodyLogicMD as an expert source. BodyLogicMD currently has 15 locations in Arizona, Erectile dysfunction medication, Florida, Illinois, New Hampshire, Ohio, Texas and Virginia.

Want to stay up to date on the latest news and views about bioidentical hormone therapy? Subscribe to BodyLogicMD's bioidentical hormone therapy blog at http://bodylogicmd.wordpress.com/

Media and bloggers: contact Lisa Buyer lbuyer(at)thebuyergroup.com at www.thebuyergroup.com

###

BodyLogicMD
Lisa Buyer
954-354-1411
E-mail Information

Trackback URL: http://prweb.com/pingpr.php/SW5zZS1UaGlyLUZhbHUtTWFnbi1UaGlyLVplcm8=

WASHINGTON (Reuters) - The male impotence drug Viagra may be useful for treating jet lag as well, according to Argentine researchers who gave it to hamsters made to feel like rodent globe-trotters.

The researchers manipulated the schedule of turning lights on and off to induce jet lag in the laboratory animals, they reported on Monday in the Proceedings of the National Academy of Sciences

National Academy of Sciences.

Adult male hamsters given Viagra, also called sildenafil, recovered from jet lag up to 50 percent faster than hamsters that were not given it, the researchers said.

The scientists stopped giving the hamsters the highest dose they had been using in the experiment due to a certain side effect.

“However, we used the intermediate dose for the rest of the experiments because at that dose animals did not manifest the effects of sildenafil-induced penile erections,” they wrote.

Flying across multiple time zones can confuse one's sleep-wake cycle, resulting in the condition called jet lag, marked by insomnia, sleepiness and difficulty erectile dysfunction symptoms
.

Researchers Patricia Agostino, Santiago Plano and Diego Golombek of the Treating impotence Nacional de Quilmes in Buenos Aires gave doses of Viagra to the hamsters at night, then switched on bright lights six hours early to simulate eastbound flight.

They judged how well the hamsters adjusted to the changes by observing when they began running on exercise wheels.

The drug helped the rodents cope with jet lag only when given before the equivalent of an eastbound flight, not the reverse when they delayed turning on lights to simulate westbound travel, the study found.

The researchers said the findings suggested that Viagra could be useful to help people cope with jet lag or shift work. They said the dose needed for such uses could be lower than the one used for treatment of erectile psychological impotence.

Viagra interferes with an enzyme that lowers levels of a naturally occurring compound that plays a role in the regulation of the circadian cycle, the body's internal clock, the researchers said.

Viagra is marketed by Pfizer, the world's largest drug maker. The U.S. Food and Drug Drug for treatment of erectile dysfunction

Food and Drug Administration approved it to treat erectile dysfunction in 1998.

Botox is not just for wrinkles anymore. New research suggests that it may boost the quality of life of men with enlarged prostate when injected directly into the gland.

The small study revealed that about 75 percent of men suffering from benign prostatic hyperplasia (BPH) experienced partial symptom relief following the treatment.

“Many men have enlarged prostate,” noted study senior author Dr. Michael B. Chancellor, a professor of urology at the University of Pittsburgh Medical Center. “They take pills, but sometimes they don't work, or sometimes they have side effects, and they're afraid of surgery. So now, Botox has been shown to be safe and effective, and a single office injection, which takes about 5 minutes, can achieve success for one entire year. So, it's a new and very exciting alternative that is something between standard drugs and surgery.”

Chancellor was slated to present the findings this week in Anaheim, Calif., at the annual meeting of the American Urological Association. He conducted his work alongside colleagues at the Chang Gung University Medical College in Taiwan.

“This is not surprising, but it's very interesting,” added Dr. Peter T. Scardino, chairman of the department of urology and head of the Prostate Cancer Program at Memorial Sloan-Kettering Cancer Center in New York City. “Erectile dysfunction medication, what you're doing with Botox is not so much changing the prostate size as relaxing the nerves and muscle tone in the prostate and making urinary flow easier. It certainly makes sense.”

Scardino was not involved in the study, which was funded by the pharmaceutical company Allergan Inc, the maker of Botox.

According to the National Kidney and Urologic Diseases Erectile help Impotence device, BPH usually occurs among men over the age of 50. More than half of all men over the age of 60 develop BPH, the authors noted — a figure that rises to 80 percent by the age of 80.

Between 40 percent and 50 percent of BPH patients develop a loss of bladder control as the growing prostate squeezes against the urethra, the passage through which urine flows.

Accompanying symptoms include a frequent need to urinate (often at night), trouble urinating (even when feeling the urge), blood in the urine, and urinary tract infections. In severe cases, bladder and kidney damage can result.

Physicians diagnose BPH by means of digital rectal exams, blood tests, X-rays, sonograms, or cystoscopy — the insertion of a lighted tube into the bladder.

Once identified, patients with mild BPH may choose to forego treatment. However, those with more serious symptoms are often prescribed medications to shrink or relax the gland to relieve bladder blockage.

Doctors use a number of drugs, often in combination, to treat BPH. When that fails, the prostate can be reduced or removed via laser or microwave techniques, or invasive surgery.

In this study, Chancellor and his colleagues honed in on Botox as a possible treatment alternative.

The researchers focused on 37 men, averaging 67 years of age, who had not responded to standard treatments for BPH.

Using an ultrasound guide, the patients were injected once with between 100 and 200 units of Botox, depending on the size of the prostate.

The team found that nearly three-quarters of the patients experienced a 30 percent improvement in their symptoms for up to a year following the injection. None of the patients experienced significant side effects, such as erectile dysfunction or urinary incontinence.

Follow-up exams conducted six months and 12 months following treatment also showed an up to 15 percent reduction in prostate size among some, but not all, patients. According to the researchers, this suggests Botox instigated a controlled form of prostate cell death that shrank the gland.

However, these reductions in prostate size did not seem to explain symptom improvement, they said. Rather, symptom relief was probably associated with a change in prostate gland muscle tone and sensory function following Botox injections.

“In fact, the effect of the Botox is similar to what the alpha-blockers drugs do and have done for many years,” noted Scardino. “But, I can imagine this being useful as an alternate to a more invasive procedure for people who all of a sudden can't urinate and face an emergency situation.”

“The question is how practical is it?” Scardino cautioned. “It's worth exploring, but this is extremely impotence help
in terms of its clinical benefit. Much more research is needed.”

Chancellor agreed on the need for more research and said a new worldwide study is already under way to explore Botox's potential against BPH.

Dr. Robert E. Weiss is a urologic oncologist at The Cancer Institute of New Jersey and an associate professor of urology at the Robert Wood Johnson Medical School in New Brunswick, N.J. He said that patients who have failed standard medical therapies have the most to gain from this alternative approach.

“We have a significant number of patients nowadays who begin medical therapy, and either it initially doesn't work, or, with time their symptoms get worse,” he noted. “And the next step would be a more invasive treatment. So, this would probably be a little better option, because it's presumably minimally invasive. It's certainly a novel idea.”

More information

For more on BPH and its treatment, visit the U.S. National Institutes of Health.

CHICAGO (Reuters) - The type of prostate cancer treatment a man gets has a lot to do with the kind of specialist he sees first, according to a study released on Monday that lends scientific evidence to something many men have likely guessed.

Prostate cancer can be treated effectively using radiation, radioactive seeds or surgical removal of the prostate. Surgery or drugs to stop production of testosterone, known as hormone therapy, may also be used in high-risk patients.

Doctors often also advise close medical observation, also known as watchful waiting.

Each treatment is associated with different benefits and side effects. Prostate surgery can cause urinary masturbation and erectile dysfunction and erectile dysfunction; radiation therapy can cause diarrhea and erectile dysfunction; and hormone therapy can cause hot flashes and breast tenderness.

“You want your physician to convey this information without a bias,” Dr. Thomas Jang, a urologist from Memorial Man impotence Cancer Center in New York, said at the annual meeting of the American Society of Clinical Caffeine impotence.

Although the 5-year survival rate for men with localized prostate cancer is nearly 100 percent, it is the third most common cause of cancer death in men of all ages, and the most common cause of cancer death in men over 75.

No scientific studies have proven which therapy works best, so men typically follow their doctor's recommendation, said Jang.

The study of more than 85,000 men aged 65 and older with prostate cancer that had not yet spread uncovered a strong alternative medicine for impotence between physician type and treatment.

If a man's doctor happens to be a urologist, for example, the recommendation for men under 70 most often will be surgery — 70 percent of the time. For men over 75 who saw only a urologist, the choice was watchful waiting or hormone therapy in 91 percent of the patients.

But if they saw both a urologist and a radiation oncologist, 78 percent of younger men and 85 percent of older men got radiation therapy.

Because patients tend to fare well on all the treatment options, the choice comes down to which side effects and treatment options best fit the patient, Dr. Justin Bekelman, a radiation oncologist at Memorial Sloan-Kettering, who worked on the study, said in an interview.

“It's not enough to say, Google it and check it out,” he said.

Most prostate cancer patients tend to see a urologist first because they are the doctors who perform biopsies and make diagnoses.

“I think urologists as gatekeepers have to present balanced information,” Jang said.

The American Cancer SocietyP.S.

American Cancer Society expects 218,890 U.S. men to be diagnosed with prostate cancer in 2007 and 27,000 to die of it.

SUNDAY, June 3 (HealthDay News) — Gene therapy using nerve growth factors reversed erectile erectile dysfunction and the prostate
in rats within four weeks, say University of Pittsburgh School of Medicine researchers.

Erectile dysfunction (ED) affects between 15 million and 30 million men in the United States. Many men suffer nerve overcoming impotence ED after surgery for prostate cancer.

The Pittsburgh team found that the genes for the “glial cell line derived neurotrophic factor” (GDNF) and the GDNF family ligand, called neurturin, were both effective in treating erectile dysfunction in the rats. The genes were placed in a genetically natural cure for impotence in man herpes simplex virus, which was then injected into the rats' damaged cavernous nerve.

The finding suggests a potential new treatment for ED in men.

“Because the herpes virus persists in the nerve cell for as long as it is alive and nerve cells typically do not reproduce, this represents the first-ever demonstration of a long-term treatment for ED that does not rely on the chronic administration of drugs that can have potentially harmful side effects,” study co-leader Joseph C. Glorioso, chairman of the department of biochemistry and molecular genetics, said in a prepared statement.

The study was to be presented over the weekend at the annual meeting of the American Society of Gene Therapy, in Seattle.

More information

The American Urological Association has more about erectile dysfunction.